🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being performed to comply with regulatory requirements that a...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-17
Trial ID
NCT02293148
This study is intended to evaluate the dose-response relationship of GSK127...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-01
Trial ID
NCT01977482
Treatments Being Tested
This study will test the hypothesis that GSK1278863 will reduce neurologic,...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10-31
Trial ID
NCT01920594
Treatments Being Tested
The study will evaluate the ability of GSK1278863 to increase the hemoglobi...
Status
Terminated
Location
GSK Investigational Site
Start Date
2014-06-11
Trial ID
NCT02075463
Treatments Being Tested
As per non-clinical studies, prolyl hydroxylase inhibitor GSK1278863 can pr...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-01-15
Trial ID
NCT02231190
Treatments Being Tested
This Phase 3 study in hemodialysis-dependent subjects with anemia will eval...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-09-05
Trial ID
NCT03400033
Treatments Being Tested
This study aims to characterize the relationship between dose of GSK1278863...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-11-05
Trial ID
NCT02019719
Treatments Being Tested
This study will be conducted in approximately 228 subjects with anemia asso...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-10-31
Trial ID
NCT01977573
Treatments Being Tested
GSK1278863 is an orally available, hypoxia-inducible factor - prolyl hydrox...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-02-17
Trial ID
NCT02689206
Treatments Being Tested
The purpose of this study is to characterize the safety and tolerability of...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-08-12
Trial ID
NCT00935831
Treatments Being Tested